行情

TTOO

TTOO

T2 Biosystems
NASDAQ

实时行情|Nasdaq Last Sale

1.170
+0.030
+2.63%
盘后: 1.180 +0.01 +0.85% 19:33 01/17 EST
开盘
1.130
昨收
1.140
最高
1.200
最低
1.130
成交量
35.72万
成交额
--
52周最高
5.38
52周最低
0.5200
市值
5,461.46万
市盈率(TTM)
-0.8670
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

TTOO 新闻

  • T2 Biosystems gives new CEO option award; shares up
  • seekingalpha.1天前
  • T2 Biosystems Reports Granting of Inducement Award
  • GlobeNewswire.1天前
  • T2 Biosystems Promotes Tony Pare to Chief Commercial Officer
  • GlobeNewswire.5天前
  • T2 Bio up 7% premarket on preliminary Q4 results
  • seekingalpha.01/10 18:43

更多

所属板块

先进医疗设备和技术
+0.57%
医疗设备和用品
+0.29%

热门股票

名称
价格
涨跌幅

TTOO 简况

T2 Biosystems, Inc. is an in vitro diagnostics company engaged in developing a technology platform offering an alternative to diagnostic methodologies. The Company's T2 Magnetic Resonance platform (T2MR) enables detection of pathogens, biomarkers and other abnormalities in a range of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as one colony forming unit per milliliter (CFU/mL). The Company's initial development efforts target sepsis, hemostasis and Lyme disease. T2MR is a miniaturized, magnetic resonance-based approach that measures how water molecules react in the presence of magnetic fields. Its platform detects a range of targets, including molecular targets, such as deoxyribonucleic acid (DNA), immunodiagnostics, such as proteins, and a range of hemostasis measurements. The Company offers T2Dx Instrument (T2Dx) and the T2Candida Panel.
展开

Webull提供T2 Biosystems Inc的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。